[1]
Chiorescu, S., Andercou, O.A., Grad, N.O. and Mironiuc, I.A. 2018. Intraperitoneal Administration of Rosuvastatin Prevents Postoperative Peritoneal Adhesions by Decreasing the Release of Tumor Necrosis Factor. Medicine and Pharmacy Reports. 91, 1 (Jan. 2018), 79-84. DOI:https://doi.org/10.15386/cjmed-859.